TFAM and cardiomyopathy: Similarly, a beneficial impact was also evident in the m.C5024T tRNAAla mouse model, where moderate overexpression of TFAM and the associated mtDNA increase improved the cardiomyopathy phenotype in aged mice (Filograna et al., 2019).